Allan graduated in 1982 with a Bachelor of Pharmacy at the South Australian Institute of Technology, UniSA’s antecedent institution. In 1989, he obtained his PhD in clinical pharmacology from the University of Adelaide. He followed this with post-doctoral experience at the University of Manchester, UK.
Allan has been an academic at UniSA for over 25 years, taking on various leadership positions including Senior Lecturer and Associate Professor. He was promoted to Professor in Pharmaceutics in 2003. The following year, he became Head of the School of Pharmacy and Medical Sciences, where he was instrumental in establishing the Sansom Institute (now the Division-based Sansom Institute for Health Research) and in supporting... Read more
About me
Allan graduated in 1982 with a Bachelor of Pharmacy at the South Australian Institute of Technology, UniSA’s antecedent institution. In 1989, he obtained his PhD in clinical pharmacology from the University of Adelaide. He followed this with post-doctoral experience at the University of Manchester, UK.
Allan has been an academic at UniSA for over 25 years, taking on various leadership positions including Senior Lecturer and Associate Professor. He was promoted to Professor in Pharmaceutics in 2003. The following year, he became Head of the School of Pharmacy and Medical Sciences, where he was instrumental in establishing the Sansom Institute (now the Division-based Sansom Institute for Health Research) and in supporting tremendous growth in the School’s research activity and teaching profile. In 2009, he became Pro Vice Chancellor and Vice President: Division of Health Sciences. Through his leadership, the Division registered significant growth in student numbers and experienced sustained improvement in research activity. From 2013 - 2021, Allan was UniSA’s inaugural Provost & Chief Academic Officer. As Provost, he was responsible for enhancing UniSA’s educational offerings, providing an outstanding student experience, and planning and development of the University’s academic programs. Allan has launched a whole-of-University review of the curriculum to examine the overall disciplinary profile of each School focusing on teaching quality, student engagement and satisfaction, and the uptake of the University’s blended and external delivery.
Allan has a significant research career. He has more than 100 peer-reviewed publications with over 1,400 literature citations and has held NHMRC and/or ARC grants on an ongoing basis since 1994. His research interests are broad, and include basic, clinical and commercial research into the better use of medicines as well as the development of new ways of using medicines to treat skin cancer and kidney disease. Allan’s group has attracted over $15 million in Category 1-4 research income to UniSA. Allan is former President of the Australasian Pharmaceutical Science Association (APSA) and winner of the APSA medal for outstanding contributions to pharmaceutical science.
Allan previously served as non-executive Director of CPR Pharma Services Ltd, a spin-off company that he helped to form in 2009. He has a keen interest in supporting innovation in the health and medical sector and encouraging entrepreneurial activity within UniSA.
About me
About me
Doctor of Philosophy The University of Adelaide
Bachelor of Pharmacy South Australian Institute of Technology
Research
Excludes commercial-in-confidence projects.
PK analysis research services for clinical study DTX-SPL8783, Starpharma, 04/07/2016 - 30/12/2020
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2024 |
Open access
|
2021 |
Open access
7
5
305
|
2019 |
Open access
4
4
1
|
2019 |
Open access
3
4
4
|
2015 |
Open access
22
22
1
|
2014 |
|
2014 |
Open access
15
15
1
|
2014 |
|
2013 |
4
|
2012 |
Open access
366
352
|
2012 |
2
2
|
2011 |
14
11
|
2011 |
Open access
80
69
|
2011 |
53
49
|
2011 |
Open access
38
33
|
2011 |
38
33
|
2011 |
10
8
|
2010 |
Open access
|
2010 |
30
25
|
2009 |
Open access
34
32
|
2009 |
Open access
5
|
2008 |
50
48
|
2008 |
28
28
|
Research
Research
Details | Registry | Status |
---|---|---|
NSAID-containing topical formulations that demonstrate chemopreventive activity McKinnon, Ross; Evans, Allan |
AU | Filed |
NSAID-containing topical formulations that demonstrate chemopreventive activity Evans, Allan; McKinnon, Ross |
CA | Granted |
NSAID-containing topical formulations that demonstrate chemopreventive activity Evans, Allan; McKinnon, Ross |
CN | Granted |
NSAID-containing topical formulations that demonstrate chemopreventive activity Evans, Allan; McKinnon, Ross |
EP | Filed |
NSAID-containing topical formulations that demonstrate chemopreventive activity Evans, Allan; McKinnon, Ross |
KR | Granted |
NSAID-containing topical formulations that demonstrate chemopreventive activity Evans, Allan; McKinnon, Ross |
US | Filed |
External engagement & recognition
Organisation | Country |
---|---|
Acrux Ltd | AUSTRALIA |
Centre for Health Studies | LUXEMBOURG |
CMAX | AUSTRALIA |
Cpr Pharma Services Pty Ltd | AUSTRALIA |
Drugs for Neglected Diseases initiative (DNDI) | SWITZERLAND |
Flinders University | AUSTRALIA |
Hospital for Tropical Disease | THAILAND |
Institute of Medical and Veterinary Science | AUSTRALIA |
Khon Kaen University | THAILAND |
Medicines for Malaria Venture | SWITZERLAND |
Monash University | AUSTRALIA |
National Human Genome Research Institute | UNITED STATES |
Pediatrix Screening | UNITED STATES |
Prince of Songkla University | THAILAND |
pSivida Limited | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
Sigma-Tau Industrie Farmaceutiche Riunite | ITALY |
St Vincent's Hospital | AUSTRALIA |
Taylor's University | MALAYSIA |
The Queen Elizabeth Hospital | AUSTRALIA |
The University of Notre Dame Australia | AUSTRALIA |
University of Adelaide | AUSTRALIA |
University of Groningen | NETHERLANDS |
University of Manchester | UNITED KINGDOM |
University of Otago | NEW ZEALAND |
University of Oxford | UNITED KINGDOM |
University of Science, Malaysia | MALAYSIA |
University of South Australia | AUSTRALIA |
Utrecht University | NETHERLANDS |
Women's and Children's Hospital | AUSTRALIA |
World Bank | AZERBAIJAN |
External engagement & recognition
Engagement/recognition | Year |
---|---|
DirectorCPR Pharma Pty Ltd |
2018 |
DirectorCPR Pharma Pty Ltd |
2017 |
MemberPharmaceutical Society of Australia |
2017 |
DirectorCPR Pharma Pty Ltd |
2016 |
MemberPharmaceutical Society of Australia |
2016 |
DirectorCPR Pharma Pty Ltd |
2015 |
Board MemberSouth Australian Health and Medical Research Institute (SAHMRI) |
2014 |
DirectorCPR Pharma Pty Ltd |
2014 |
Board MemberSouth Australian Health and Medical Research Institute (SAHMRI) |
2013 |
DirectorCPR Pharma Pty Ltd |
2013 |
DirectorCPR Pharma Pty Ltd |
2012 |
DirectorCPR Pharma Pty Ltd |
2011 |
APSA MedalAustralasian Pharmaceutical Science Association (APSA) |
2010 |
DirectorCPR Pharma Pty Ltd |
2010 |
DirectorCPR Pharma Pty Ltd |
2009 |
Allan has taught extensively in the area of pharmaceutical science and maintains an active scholarly interest in areas such as:
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
Development of novel micro-reservoir based buccal mucosal drug delivery systems | Completed |
Identifying COX-independent pathways involved in the anti-proliferative effects of R-flurbiprofen | Completed |
Impact of nanoparticles on the hepatic handling of drugs | Completed |
Pharmacokinetic interaction between morphine and ketamine | Completed |
Porous silicon as a delivery system for poorly soluble drugs | Completed |
The clinical impact of an altered endogenous carnitine profile | Completed |